Your browser doesn't support javascript.
loading
In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
Ke, Kunbin; Li, Hongjian; Yao, Hong; Shi, Xi-Nan; Dong, Chao; Zhu, Ying; Liu, Xu; Li, Ling; Leung, Kwong-Sak; Wong, Man-Hon; Liu, Xiao-Dong; Kung, Hsiang-Fu; Lin, Marie Chia-Mi.
Afiliação
  • Ke K; Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, China.
  • Li H; Department of Urology, The 1st Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Yao H; Institute of Future Cities, Chinese University of Hong Kong, Hong Kong, China.
  • Shi XN; Department of Computer Science and Engineering, Chinese University of Hong Kong, Hong Kong, China.
  • Dong C; The Cancer Biotherapy Institute of Jiangsu Province, Xuzhou Medical College, Xuzhou, China.
  • Zhu Y; Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, China.
  • Liu X; Department of Pathophysiology, School of Basic Medical Sciences, Yunnan University of TCM, Kunming, China.
  • Li L; Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, China.
  • Leung KS; Department of the Second Medical Oncology, The 3rd Affiliated Hospital of Kunming Medical University, Yunnan Tumor Hospital, Kunming, China.
  • Wong MH; Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, China.
  • Liu XD; Department of Cadre Medical Branch, The 3rd Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Kung HF; Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, China.
  • Lin MC; Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, China.
Chem Biol Drug Des ; 89(4): 505-513, 2017 04.
Article em En | MEDLINE | ID: mdl-27664399

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias da Bexiga Urinária / Receptor Tipo 3 de Fator de Crescimento de Fibroblastos / Acaricidas / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chem Biol Drug Des Assunto da revista: BIOQUIMICA / FARMACIA / FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias da Bexiga Urinária / Receptor Tipo 3 de Fator de Crescimento de Fibroblastos / Acaricidas / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Chem Biol Drug Des Assunto da revista: BIOQUIMICA / FARMACIA / FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido